BRAVOVAX

Wuhan BravoVax Co., Ltd (BravoVax) is a "state level high-tech enterprise" established in the year 2012 and is specialized in the R&D, manufacturing and marketing of high-end human vaccines. BravoVax is committed to the R&D and industri alization of a number of blockbuster vaccines such as novel COVID-19 Vaccine, multival ent Rot avirus Vaccine, next-generation Pneumococcal Con jugate Vaccine, broad-spectrum Human Papillomavirus (HPV) Vaccine and Recombinant Varicella-zoster Virus (HZV) Vaccine. As one of active members in Developing Countr ies Vaccine Manufacturers Network (DCVMN) and a council number of China Association for Vaccines (CAV), BravoVax will gradually push the se products into the market in accordance to China cGMP, WHO cGMP and IHC guid ance, meeting the vaccine demands in domestic and global market s, and benefiting the whole soci ety... BravoVax is promoting its achievements in novel vaccines globally, including Asian, European and Latin American governments and also..

Also known as: BravoVax Co., Ltd

Primary location: Wuhan China